[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@QueenBioInvest QueenBioInvestor

QueenBioInvestor posts on X about $dnli, $alny, dip, $crsp the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours.

Engagements: X #

• X Week XXX +74%
• X Month XXXXX +421%
• X Year XXXXX +1,188%

Mentions: X #

• X Week X +33%
• X Month XX +217%
• X Year XX +475%

Followers: XXX #

• X Week XXX +0.71%
• X Month XXX +19%
• X Year XXX +20%

CreatorRank: undefined #

Social Influence #

---

Social category influence stocks XX%

Social topic influence $dnli 25%, $alny 25%, dip 25%, $crsp 25%, $ntla 25%, $qure 25%, clarity 25%, momentum XX%

Top accounts mentioned or mentioned by @nexttradex @biotech2k1

Top assets mentioned Denali Therapeutics Inc. Common Stock (DNLI) Alnylam Pharmaceuticals, Inc. (ALNY) CRISPR Therapeutics AG (CRSP) Intellia Therapeutics, Inc (NTLA) uniQure N.V. (QURE)

Top Social Posts #

---

Top posts by engagements in the last XX hours

"@Biotech2k1 Im with you on $DNLI. Starter on todays dip; plan is add on pullbacks into the pre-PDUFA window. The $ALNY comparison makes sense platform + path can rerate fast"
X Link @QueenBioInvest 2025-10-10T15:54Z XXX followers, XXX engagements

"@Biotech2k1 I respect the COGS/payer risks but I dont avoid whole modalities. With the right setup (data + mfg + payer clarity) GT/editing can work see $CRSP/$NTLA momentum $QURE post-HD. I trade price and near catalysts with tight sizing"
X Link @QueenBioInvest 2025-10-10T11:11Z XXX followers, XXX engagements